A wrongful death lawsuit filed against USPlabs LLC, GNC Corp., affiliated entities, and USPlabs’ executives Jonathan Vincent Doyle and Jacob Geissler was “dismissed with prejudice” last week after a federal judge upheld a ruling that struck the testimony of three of plaintiffs’ experts. The experts wanted to show the dangers of the ingredient DMAA (dimethylamylamine) in UPSlabs’ Jack3d preworkout supplement, and that it was likely a contributing factor in the soldier’s death.
In this episode, Josh Long, legal and regulatory editor, and Rachel Adams, managing editor, discuss:
- Dismissal of a wrongful death lawsuit against USPlabs;
- DMAA’s availability in the market, despite FDA’s stance on the ingredient; and
- Criminal indictment of USPlabs by federal government.
Links and Resources:
- USPlabs Overcomes Lawsuit Claiming DMAA in Supplement Contributed to Soldier’s Death
- As Jury Trial Approaches, USPlabs Says DMAA Supplement Didn’t Cause Soldier’s Death
- DMAA Supplements Still on U.S. Market in Spite of FDA Enforcement
- FDA Warns DMAA Marketers
- Emails Highlighted as Incriminating Evidence in USPlabs Indictment